VeriChip Corporation Re-Launches its VeriMed Health Link Electronic Health Records System

VeriChip Corporation (NASDAQ:CHIP) ("VeriChip" or the "Company"), a provider of radio frequency identification (RFID) systems for healthcare and patient-related needs, announced today that it is re-launching its VeriMed™ Health Link electronic health records system. The Company believes its history and expertise in patient identification and EHRs will position it to benefit from stimulus funds provided under the American Recovery and Reinvestment Act (ARRA) of 2009, which authorized $23 billion in spending for healthcare information technology, with a concentration on the implementation and adoption of EHRs.

In 2004, the Company received FDA clearance of its VeriMed™ Health Link patient identification system, incorporating the implantable RFID microchip (the VeriChip), a handheld scanner for emergency room personnel and an online, electronic, personal health record. In early 2008, the Company changed the name of this system to Health Link and has enrolled a total of 536 patients in the Health Link EHR.

In July 2008, the Company sold a significant portion of its assets to The Stanley Works and substantially diminished its marketing efforts related to the Health Link system. In November 2008, the Company's former Chairman and CEO, Scott R. Silverman, purchased a majority ownership position in the Company. Since then, management has examined a wide array of business opportunities including, but not limited to, re-launching the Health Link EHR. In July 2009, the Company received $4.4 million previously held in escrow related to The Stanley Works transaction.

Commenting on the re-launch of Health Link, Mr. Silverman, VeriChip's Chairman, stated, "For years, VeriChip has been an outspoken proponent of a nationwide, interoperable electronic health records system to decrease medical errors, reduce costs for providers and insurers, and ensure the best standard of care for patients. Since our FDA clearance in 2004, we have been recognized as a leader in patient identification and electronic medical records and have played a significant role in their evolution. Not only do we offer a robust and stable, fully functioning EHR, but VeriMed Health Link offers the only secure means to access electronic health information that is guaranteed to always be with the patient."

Silverman continued, "As the Company moves forward with a comprehensive platform of identification technologies and tools, starting the process with our existing Health Link EHR is only logical."

As part of the federal government's Health Information Technology (HIT) initiative, led by its National Coordinator Dr. David Blumenthal, a significant grant program has been deployed to evolve electronic health records and the 21st century health care system. VeriChip Corporation believes it is well positioned to benefit from federal grants given to physicians and hospitals in order to evolve not only its own Health Link EHR, but, more importantly, the overall goal of a universal medical record with full functionality, interoperability and portability.

The Company has begun a process to ensure that its EHR is compliant with the certifications set by the Certification Commission for Health Information Technology (CCHIT), thereby enabling those physicians and hospitals that utilize the Company’s EHR to qualify for stimulus funding.

About VeriChip Corporation

VeriChip Corporation, headquartered in Delray Beach, Florida, has developed the VeriMed™ Health Link System for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, cleared for medical use in October 2004 by the United States Food and Drug Administration. To complement its healthcare division, VeriChip Corporation established VeriGreen Energy Corporation in March 2009 to focus and invest in the clean and alternative energy sector.

For more information on VeriChip, please call 1-800-970-2447, or e-mail info@verichipcorp.com. Additional information can be found online at www.verichipcorp.com.

Statements about VeriChip’s future expectations, including its ability to benefit from federal stimulus funding, and all other statements in this press release other than historical facts are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and VeriChip’s actual results could differ materially from expected results. Additional information about these and other factors that could affect the Company’s business is set forth in the Company’s various filings with the Securities and Exchange Commission, including those set forth in the Company’s 10-K filed on February 12, 2009, under the caption “Risk Factors.” The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

Verichip (MM) (NASDAQ:CHIP)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024